Crossmark

Hepatitis C virus recurrence in two patients who achieved sustained viral response with interferon-free direct-acting antiviral therapy: reinfection or relapse?

Crossref DOI link: https://doi.org/10.1007/s12328-019-01001-w

Published Online: 2019-06-04

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yukawa, Yoshimi

Tamori, Akihiro https://orcid.org/0000-0001-9119-4864
Iio, Etsuko

Ogawa, Shintaro

Yoshida, Kanako

Uchida-Kobayashi, Sawako

Enomoto, Masaru

Tanaka, Yasuhito

Kawada, Norifumi
License Information

Text and Data Mining valid from 2019-06-04

Version of Record valid from 2019-06-04
More Information

Article History

Received: 27 April 2019

Accepted: 27 May 2019

First Online: 4 June 2019

Compliance with ethical standards

:

: Dr. N. Kawada and Dr. A. Tamori and Dr. Y. Tanaka have received lecture fees from Gilead Sciences, and AbbVie Inc. The other authors declare that they have no conflict of interest.

: All the procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

: Informed consent was obtained from the patient for being included in the study.

Document is current

Any future updates will be listed below